Advancement of surgical treatment in prostate cancer
Harabayashi, T.; Takada, N.; Minami, K.; Nagamori, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 416-420
2016
ISSN/ISBN: 0047-1852 PMID: 27344767 Document Number: 689254
Document emailed within 1 workday
Related Documents
Kawai, K. 2007: Surgical and medical treatment for localized prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 1002-1005Wallen, E.M. 2006: Treatment for localized prostate cancer: surgical approaches North Carolina Medical Journal 67(2): 146-148
Aboyan, I.A.; Aboyan, V.E.; Orlov, Y.N.; Pakus, S.M.; Pakus, D.I. 2018: Urodynamics study in patients with urinary incontinence, after surgical treatment of localized prostate cancer Urologiia 6: 14-18
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Kaji, Y. 2016: Advancement of prostate MRi Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 85-90
Beseghi, U.; Mori, M.; Del Rossi, C.; Scuto, S.; Gelmetti, M.; Ghinelli, C. 1985: Meatal advancement and glanuloplasty incorporated (MAGPI): a new surgical technic in the treatment of distal hypospadias Acta Bio-Medica de l'Ateneo Parmense 56(6): 257-260
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Athanasiadis, S.; Oladeinde, I.; Kuprian, A.; Keller, B. 1995: Endorectal advancement flap-plasty vs. transperineal closure in surgical treatment of rectovaginal fistulas. a prospective long-term study of 88 patients Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 66(5): 493-502
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Teodorovich, O.V.; Shatokhin, M.N.; Naryshkin, S.A.; Abdullayev, M.I.; Krasnov, A.V.; Borisenko, G.G.; Zhurbenko, A.A. 2019: Focal laser coagulation in the treatment of a patient with kidney cancer and prostate cancer Urologiia 2: 55-58
Lanson, Y. 1995: Surgical treatment of benign hypertrophy of the prostate Presse Medicale 24(32): 1481-1484